This Human Rights Day, DKMS highlights the urgent need for stem cell transplants for South African children battling rare ...

Clinigen, the global speciality pharmaceutical services group, today announced that Equity Pharmaceuticals, part of the Clinigen Group, has entered into a new collaboration with Servier, an ...

This Human Rights Day, DKMS highlights the urgent need for stem cell transplants for South African children battling rare ...

The Centre’s Clinical Academics as well as providing patient clinical care and conducting lab-based research, they also participate in the development of the clinical research programme in Clinical ...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

It is proposed to create a basic organisation in the field of haematology in the Commonwealth of Independent States, and the relevant ...

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of ...

India's gene therapy for blood cancers shows 73% response rate, offering hope and cost-effective treatment for patients.

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese ...